AQR Capital Management
ALDR

AQR Capital Management’s Alder Biopharmaceuticals ALDR Stock Holding History

AQR Capital Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-25,097
Closed -$257K – 2273
2018
Q4 		$257K Buy
25,097
+4,304
+21% +$55.1K ﹤0.01% 2014
2018
Q3 		$346K Buy
+20,793
New +$376K ﹤0.01% 2069
2016
Q4 		– Sell
-23,319
Closed -$764K – 2311
2016
Q3 		$764K Sell
23,319
-4,177
-15% -$127K ﹤0.01% 1811
2016
Q2 		$687K Sell
27,496
-9,299
-25% -$252K ﹤0.01% 1746
2016
Q1 		$901K Buy
36,795
+6,579
+22% +$152K ﹤0.01% 1617
2015
Q4 		$998K Sell
30,216
-19,636
-39% -$664K ﹤0.01% 1572
2015
Q3 		$1.63M Buy
49,852
+23,718
+91% +$1.01M ﹤0.01% 1222
2015
Q2 		$1.38M Buy
+26,134
New +$950K ﹤0.01% 1348

Other funds holding ALDR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return